T1	HMM 58 74	serum bile acids
T2	HMM 302 314	tolerability
T3	HMM 326 346	bile acid metabolism
T4	HMM 830 847	study, bile acids
T5	HMM 862 973	by HPLC-MS in plasma and faeces, and fibroblast growth factor 19 (FGF19) and 7α-hydroxy-4-cholesten-3-one (C4)
T6	HMM 999 1032	RESULTS No serious adverse events
T7	HMM 1138 1178	study, plasma total bile acids and FGF19
T8	HMM 1303 1316	(P < 0.05).
T9	HMM 1317 1342	Plasma C4 and faecal bile
T10	HMM 1528 1546	majority of faecal
T11	HMM 1709 1749	interrupts the enterohepatic circulation
